Cardiovascular effects of esmolol alone and in combination with levosimendan during septic shock

• Conditions: MedDRA version: 18.0Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestations; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2012-003012-31-FR
• Lead Sponsor: DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09-23
• Last Update Posted: 28 September 2015

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

NO
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

NO

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified